Insider Trading History of Hagen Steven R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Hagen Steven R since 2008. The trader's CIK number is 1449207. At the time of the last reporting, Hagen Steven R was the VP Pharmaceutical De of Albany Molecular Research Inc. (stock ticker symbol AMRI). Also see all insider trading activities at Albany Molecular Research Inc.



Yearly summary of insider trading at Albany Molecular Research Inc (AMRI) by Hagen Steven R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 AMRI 0 $0 13,547 $215,140 9,000 $118,800
2015 AMRI 0 $0 41,322 $777,119 34,250 $314,259
2014 AMRI 0 $0 45,194 $756,486 40,500 $224,204
2013 AMRI 0 $0 10,890 $112,422 2,500 $7,325
2012 AMRI 0 $0 8,445 $25,130 0 $0
2011 AMRI 0 $0 2,423 $8,467 0 $0
2010 AMRI 0 $0 3,501 $19,964 0 $0
2009 AMRI 0 $0 6,400 $57,905 0 $0
2008 AMRI 0 $0 5,111 $47,854 0 $0


Insider trading of Albany Molecular Research Inc (AMRI) by Hagen Steven R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-30 AMRI Sale 9,000 16.71 150,390
2016-11-30 AMRI Option Ex 9,000 13.20 118,800
2016-11-10 AMRI Sale 785 16.79 13,180
2016-08-09 AMRI Sale 1,401 15.29 21,421
2016-05-13 AMRI Sale 2,361 12.77 30,149
2015-08-17 AMRI Sale 1,000 20.45 20,450
2015-08-17 AMRI Option Ex 1,000 13.20 13,200
2015-08-07 AMRI Sale 5,000 21.06 105,300
2015-08-07 AMRI Option Ex 5,000 13.20 66,000
2015-06-08 AMRI Sale 5,000 19.99 99,949
2015-06-08 AMRI Option Ex 5,000 10.43 52,150
2015-06-04 AMRI Sale 787 19.58 15,409
2015-05-08 AMRI Option Ex 14,500 10.05 145,797
2015-05-08 AMRI Sale 14,500 19.27 279,487
2015-03-17 AMRI Sale 3,500 18.53 64,855
2015-03-13 AMRI Sale 441 18.79 8,286
2015-03-11 AMRI Sale 721 18.30 13,194
2015-02-23 AMRI Sale 3,750 16.22 60,824
2015-02-23 AMRI Option Ex 3,750 5.99 22,462
2015-02-18 AMRI Option Ex 5,000 2.93 14,650
2015-02-18 AMRI Sale 6,623 16.51 109,365
2014-11-14 AMRI Option Ex 10,500 8.31 87,255
2014-11-14 AMRI Sale 10,500 16.06 168,630
2014-11-10 AMRI Option Ex 7,500 5.99 44,925
2014-11-10 AMRI Sale 7,500 17.03 127,725
2014-08-28 AMRI Sale 1,250 19.74 24,674
2014-08-28 AMRI Option Ex 1,250 5.25 6,562
2014-08-08 AMRI Option Ex 10,000 5.25 52,500
2014-08-08 AMRI Sale 10,797 18.99 205,035
2014-06-03 AMRI Option Ex 2,500 2.93 7,325
2014-06-03 AMRI Sale 2,500 16.93 42,325
2014-05-16 AMRI Option Ex 1,250 2.93 3,662
2014-05-16 AMRI Sale 1,250 15.45 19,312
2014-05-09 AMRI Option Ex 2,500 2.93 7,325
2014-05-09 AMRI Sale 3,397 14.80 50,275
2014-05-12 AMRI Option Ex 2,500 2.93 7,325
2014-05-12 AMRI Sale 2,500 15.27 38,175
2014-02-25 AMRI Sale 2,500 15.19 37,975
2014-02-25 AMRI Option Ex 2,500 2.93 7,325
2014-02-21 AMRI Sale 1,500 14.87 22,305
2014-02-19 AMRI Sale 1,500 13.37 20,055
2013-12-04 AMRI Sale 2,500 10.93 27,325
2013-12-04 AMRI Option Ex 2,500 2.93 7,325
2013-11-22 AMRI Sale 2,300 11.55 26,565
2013-05-29 AMRI Sale 800 11.26 9,008
2013-05-10 AMRI Sale 1,200 10.40 12,480
2013-03-18 AMRI Sale 249 9.98 2,485
2013-03-19 AMRI Sale 180 9.91 1,783
2013-03-12 AMRI Sale 677 10.75 7,277
2013-03-07 AMRI Sale 1,000 9.56 9,560
2013-02-22 AMRI Sale 984 8.18 8,049
2013-02-19 AMRI Sale 1,000 7.89 7,890
2012-11-05 AMRI Sale 372 3.51 1,305
2012-08-24 AMRI Sale 1,000 3.22 3,220
2012-08-09 AMRI Sale 3,000 3.00 9,000
2012-06-05 AMRI Sale 504 2.28 1,149
2012-05-15 AMRI Sale 2,400 3.01 7,223
2012-03-19 AMRI Sale 1,078 2.77 2,991
2012-03-06 AMRI Sale 91 2.66 242
2011-11-14 AMRI Sale 382 2.62 1,000
2011-11-04 AMRI Sale 1,139 3.11 3,542
2011-05-06 AMRI Sale 198 4.84 958
2011-03-18 AMRI Sale 617 4.18 2,579
2011-03-07 AMRI Sale 87 4.46 388
2010-12-06 AMRI Sale 2,000 5.20 10,400
2010-11-14 AMRI Sale 887 5.77 5,117
2010-11-10 AMRI Sale 355 6.09 2,161
2010-03-09 AMRI Sale 259 8.83 2,286
2009-11-19 AMRI Sale 1,500 8.05 12,075
2009-11-16 AMRI Sale 2,000 8.47 16,940
2009-08-06 AMRI Sale 900 8.79 7,910
2009-02-12 AMRI Sale 2,000 10.49 20,980
2008-11-20 AMRI Sale 2,400 8.96 21,504
2008-11-17 AMRI Sale 2,711 9.72 26,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hagen Steven R (VP Pharmaceutical De of Albany Molecular Research Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.